Patent Owner's Motion to Expunge | Apr 8, 2021 | PAPER | PATENT OWNER |
CAFC Mandate | Mar 19, 2021 | PAPER | BOARD |
Mylan's Notice of Appeal | Dec 23, 2019 | PAPER | PETITIONER |
CAFC Decision and Mandate (March 14, 2019) | Dec 12, 2019 | PAPER | BOARD |
Final Written Decision on Remand | Oct 22, 2019 | PAPER | BOARD |
Petitioner's Reply Brief on Remand | Jun 21, 2019 | PAPER | PETITIONER |
Patent Owner's Responsive Brief on Effect of CAFC Decision | Jun 7, 2019 | PAPER | PATENT OWNER |
Petitioner's Brief Addressing Effect of CAFC Decision | May 10, 2019 | PAPER | PETITIONER |
ORDER
Conduct of the Proceeding
37 C.F.R. ¿¿ 42.5 | Apr 9, 2019 | PAPER | BOARD |
Patent Owner Fourth Update to Mandatory Notices | Mar 7, 2019 | PAPER | PATENT OWNER |
PANEL CHANGE ORDER
Conduct of the Proceedings
37 C.F.R. ¿¿ 42.5 | Feb 14, 2019 | PAPER | BOARD |
Patent Owner Third Update to Mandatory Notices | Jan 24, 2019 | PAPER | PATENT OWNER |
Sanofi Mature IP Power of Attorney | Jan 24, 2019 | PAPER | PATENT OWNER |
Patent Owner's Notice of Appeal | Nov 17, 2017 | PAPER | PATENT OWNER |
Order Conduct of the Proceeding | Nov 14, 2017 | PAPER | BOARD |
Patent Owner's Motion to Preserve the Record Pending Appeal | Nov 6, 2017 | PAPER | PATENT OWNER |
Decision - On Motions to Seal | Sep 26, 2017 | PAPER | BOARD |
Final Written Decision | Sep 21, 2017 | PAPER | BOARD |
Record of Oral Hearing | Jul 20, 2017 | PAPER | BOARD |
Patent Owner's Brief in Support of Petitioner's Motions to Seal Patent Owner's Confidential Information (Papers 45, 65, 76, 88, 91) | Jun 5, 2017 | PAPER | PATENT OWNER |
REDACTED - Exhibit 1042 - Tate Deposition Transcript | May 24, 2017 | EXHIBIT | PETITIONER |
Certificate of Service | May 24, 2017 | PAPER | PETITIONER |
REDACTED - Mylan Laboratories Limited's Response to Patent Owners Motion for Observations re Robert McSorley | May 24, 2017 | PAPER | PETITIONER |
REDACTED - Petitioner's Reply in Support of Motion to Exclude | May 24, 2017 | PAPER | PETITIONER |
Patent Owner's Response to Petitioner's Motion for Observations on the Cross-Examination of Dr. Alton Oliver Sartor | May 22, 2017 | PAPER | PATENT OWNER |
Petitioner Mylan Laboratories Limited¿¿¿s Motion to Seal | May 22, 2017 | PAPER | PETITIONER |
Petitioner Mylan Laboratories Limited¿¿¿s Response to Patent Owner¿¿¿s Motion for Observations on the Cross-Examination of Dr. Rahul Seth | May 22, 2017 | PAPER | PETITIONER |
PROTECTIVE ORDER MATERIAL - Petitioner Mylan Laboratories Limited¿¿¿s Response to Patent Owner¿¿¿s Motion for Observations on the Cross-Examination of Mr. Robert McSorley | May 22, 2017 | PAPER | PETITIONER |
Patent Owner's Exhibit List 12 | May 19, 2017 | PAPER | PATENT OWNER |
PROTECTIVE ORDER MATERIAL - Petitioner's Reply in Support of Motion to Exclude | May 19, 2017 | PAPER | PETITIONER |
Patent Owner's Reply in Support of Patent Owner's Motion to Exclude Exhibits 1089-1090 | May 19, 2017 | PAPER | PATENT OWNER |
Exh. 2262 Second Evidentiary Declaration of Patrick M. Medley (served Exhibit 1095) | May 19, 2017 | EXHIBIT | PATENT OWNER |
Petitioner's Motion to Seal Reply in Support of Motion to Exclude | May 19, 2017 | PAPER | PETITIONER |
Patent Owner's Motion for Observations on Cross-Examination of Dr. Rahul Seth | May 15, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion for Observations on Cross-Examination of Mr. Robert McSorley (Public Version) | May 15, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion for Observations on Cross-Examination of Mr. Robert McSorley (Confidential, Protective Order Material Version) | May 15, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion to Seal Patent Owner's Motion for Observations on Cross-Examination of Mr. Robert McSorley | May 15, 2017 | PAPER | PATENT OWNER |
Motion for Observations Regarding the Cross-Examination of Dr. Alton Oliver Sartor | May 15, 2017 | PAPER | PETITIONER |
Exhibit 1098- May 8, 2017 Sartor Deposition Transcript | May 15, 2017 | EXHIBIT | PETITIONER |
Updated Exhibit List | May 15, 2017 | PAPER | PETITIONER |
Patent Owner's Reply in Support of Patent Owner's Motion to Seal the Reply Brief and Exhibit 2258 | May 12, 2017 | PAPER | PATENT OWNER |
Exh. 2240 Red Book Screenshot Xofigo | May 12, 2017 | EXHIBIT | PATENT OWNER |
Exh. 2241 Red Book Screenshot Jevtana | May 12, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Exhibit List 11 | May 12, 2017 | PAPER | PATENT OWNER |
Patent Owner's Opposition to Petitioner's Motion to Exclude (Protective Order Material, Confidential Version) | May 12, 2017 | PAPER | PATENT OWNER |
Patent Owner's Opposition to Petitioner's Motion to Exclude (Public Version) | May 12, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion to Seal Patent Owner's Opposition to Petitioner's Motion to Exclude | May 12, 2017 | PAPER | PATENT OWNER |
Exhibit 2235 1/17/17 Tate Declaration Regarding Exhibits | May 12, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2236 Red Book: A Comprehensive, Consistent Drug Pricing Resource | May 12, 2017 | EXHIBIT | PATENT OWNER |
Exh. 2237 Red Book from Thomson Reuters Continues Providing Average Wholesale Prices (PR Newswire 2010) | May 12, 2017 | EXHIBIT | PATENT OWNER |
Exh. 2238 Red Book Screenshot Xtandi | May 12, 2017 | EXHIBIT | PATENT OWNER |
Exh. 2239 Red Book Screenshot Zytiga | May 12, 2017 | EXHIBIT | PATENT OWNER |
Exh. 2242 Understanding Red Book Online Search Results, Truven Health Analytics | May 12, 2017 | EXHIBIT | PATENT OWNER |
Confidential Petitioner's Opp. to Patent Owner's Motion to Exclude Exhibits 1089 and 1090 | May 12, 2017 | PAPER | PETITIONER |
Petitioners Updated List of Exhibits - May 12, 2017 | May 12, 2017 | PAPER | PETITIONER |
Motion to Seal Opposition to Motion to Exclude | May 12, 2017 | PAPER | PETITIONER |
Public Petitioner's Opp. to Patent Owner's Motion to Exclude Exhibits 1089 and 1090_Redacted | May 12, 2017 | PAPER | PETITIONER |
Exhibit 1094- Evidentiary McSorley Declaration_Public | May 12, 2017 | EXHIBIT | PETITIONER |
Exhibit 2261 McSorley Deposition Transcript 4/19/17 PUBLIC Version | May 10, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Certificate of Service (Public Version 2261) | May 10, 2017 | PAPER | PATENT OWNER |
REDACTED Copy of Paper No. 64 - Petitioner Mylan Laboratories Limited's Motion to Exclude Evidence | May 9, 2017 | PAPER | PETITIONER |
REDACTED - Exhibit 1042 - Tate Deposition Transcript | May 9, 2017 | EXHIBIT | PETITIONER |
Petitioner Mylan Laboratories Limited's Certificate of Service | May 9, 2017 | PAPER | PETITIONER |
Order - Request for Oral Argument | May 8, 2017 | PAPER | BOARD |
Patent Owner's Motion to Exclude Exhibits 1089-1090 | May 2, 2017 | PAPER | PATENT OWNER |
Exhibit 2261 McSorley Deposition Transcript 4/19/17 (Protective Order Material, Confidential Version) | May 2, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Motion to Seal Exhibit 2261 | May 2, 2017 | PAPER | PATENT OWNER |
Patent Owner's Exhibit List 10 | May 2, 2017 | PAPER | PATENT OWNER |
PROTECTIVE ORDER MATERIAL - Petitioner Mylan Laboratories Limited's Motion to Exclude Evidence | May 2, 2017 | PAPER | PETITIONER |
Petitioner Mylan Laboratories Limited's Motion to Seal | May 2, 2017 | PAPER | PETITIONER |
Petitioner Mylan Laboratories Limited's Updated List of Exhibits | May 2, 2017 | PAPER | PETITIONER |
Exhibit 1096 - Wells Fargo June 2013 | May 2, 2017 | EXHIBIT | PETITIONER |
Exhibit 1097 - Wells Fargo June 2014 | May 2, 2017 | EXHIBIT | PETITIONER |
Patent Owner's Request for Oral Argument | Apr 28, 2017 | PAPER | PATENT OWNER |
Petitioner's Request for Oral Argument | Apr 28, 2017 | PAPER | PETITIONER |
Petitioner's Opposition to Patent Owner's Motion to Seal (Paper 54) | Apr 26, 2017 | PAPER | PETITIONER |
Petitioner's Notice of Deposition of Alton Oliver Sartor, M.D. | Apr 24, 2017 | PAPER | PETITIONER |
Patent Owner's Motion to Seal Exhibit 2211 | Apr 21, 2017 | PAPER | PATENT OWNER |
Exhibit 2211 2006-6-29 Email re Meeting Minutes (Public Version) | Apr 21, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Reply in Support of the Contingent Motion to Amend (Protective Order Material, Confidential Version) | Apr 20, 2017 | PAPER | PATENT OWNER |
Exhibit 2234 Declaration of Patricia Matthews, RN, BSN | Apr 20, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2258 Seth Deposition Transcript 4/14/17 (Protective Order Material, Confidential Version) | Apr 20, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2258 Seth Deposition Transcript 4/14/17 (Public Version) | Apr 20, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2259 Reply Declaration of Alton Oliver Sartor, MD | Apr 20, 2017 | EXHIBIT | PATENT OWNER |
Exhibit 2260 June 2007 Emcyt Label | Apr 20, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Exhibit List 9 | Apr 20, 2017 | PAPER | PATENT OWNER |
Patent Owner's Reply in Support of the Contingent Motion to Amend (Public Version) | Apr 20, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion to Seal the Reply Brief and Exhibit 2258 | Apr 20, 2017 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Mr. Robert McSorley | Apr 10, 2017 | PAPER | PATENT OWNER |
Notice of Second Joint Stipulation to Modify the Scheduling Order | Apr 6, 2017 | PAPER | PATENT OWNER |
Patent Owner's Notice of Deposition of Dr. Rahul Seth | Apr 6, 2017 | PAPER | PATENT OWNER |
Petitioner Updated Exhibit List | Mar 28, 2017 | PAPER | PETITIONER |
Corrected Exhibit 1067 | Mar 28, 2017 | EXHIBIT | PETITIONER |
Patent Owner's Objections to Evidence Submitted by Mylan on March 14, 2017 | Mar 21, 2017 | PAPER | PATENT OWNER |
Exhibit 1043 - Reply Declaration of Rahul Seth | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1045 - 2008 NCCN antiemesis | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1047 - Trudeau | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1041 - Sartor Deposition Transcript | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1042 - Tate Deposition Transcript | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1046 - Takenaka | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1075 - Ma Article | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1076 - CBO promotional spending for presecription drugs | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1052 - Biogen 1022A, NCT00168701_archive | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1053 - Michael | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1081 - United States Patent 5698582 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1056 - MYLAN N.V 2016 Form 10-K - Part 1 of 5 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1056 - MYLAN N.V 2016 Form 10-K - Part 2 of 5 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1083 - United States Patent 6331635 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1084 - United States Patent 6372780 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1056 - MYLAN N.V 2016 Form 10-K - Part 3 of 5 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1056 - MYLAN N.V 2016 Form 10-K - Part 4 of 5 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1086 - United States Patent 4814470 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1092 - Sanofi_20-F_2016 - Part 1 of 4 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1092 - Sanofi_20-F_2016 - Part 3 of 4 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1060 - Docetaxel label | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1048 - Hudis | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1049 - Doenicke | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1050 - Cabrespine | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1077 - Manchanda_Honka_ Final | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1051 - Padhani | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1078 - Wazana article | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1080 - United States Patent 5438072 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1055 - Defendant's Answer in 15-cv-3392 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1082 - United States Patent 5847170 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1085 - United States Patent 6387946 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1087 - United States Patent 5714512 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1088 - United States Patent 5750561 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1056 - MYLAN N.V 2016 Form 10-K - Part 5 of 5 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1091 - 2016 Orange Book | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1057 - Hoechst Aktiengesellschaft German company Britannica | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1092 - Sanofi_20-F_2016 - Part 2 of 4 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1059 - 2011 Orange Book | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1061 - FDA Grants Expanded Indication for Enzalutamide (Xtandi) - MedScape | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1062 - Mitoxantrone - Chemotherapy Drugs - Chemocare | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1063 - Estramustine - Chemocare | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1092 - Sanofi_20-F_2016 - Part 4 of 4 | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1067 - Jevtana Label | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1073 - PR Tufts CSDD 2014 Cost Study _ Tufts Center for the Study of Drug Development | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1054 - EOP2 Briefing Document | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1065 - SA_JEV_2152659 | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1068 - SA_JEV_0836005 | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1069 - SA_JEV_0866535 | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1072 - SA_JEV_1025400 | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1079 - SA_JEV_0244978 - Part 1 of 2 | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1079 - SA_JEV_0244978 - Part 2 of 2 | Mar 14, 2017 | EXHIBIT | PETITIONER |
IPR2016-00712 - PROTECTIVE ORDER MATERIAL - Opposition to Contingent Motion to Amend | Mar 14, 2017 | PAPER | PETITIONER |
Exhibit 1064 - Ketoconazole in Advanced Prostate Cancer | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1066 - Off-Label Drug Use | Mar 14, 2017 | EXHIBIT | PETITIONER |
Exhibit 1093 - Press Announcements FDA Approves New Treatment for Advanced Prostate Cancer | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1043 - Reply Declaration of Rahul Seth | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1070 - SA_JEV_0843600 | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1071 - SA_JEV_1041118 | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1074 - SA_JEV_0859285 | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1089 - Cabazitaxel IMS 2009-10 DollarsDoses | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1090 - Cabazitaxel IMS 2011-16 DollarsDoses | Mar 14, 2017 | EXHIBIT | PETITIONER |
PROTECTIVE ORDER MATERIAL - Exhibit 1042 - Tate Deposition Transcript | Mar 14, 2017 | EXHIBIT | PETITIONER |
IPR2016-00712 - Petitioner's Reply | Mar 14, 2017 | PAPER | PETITIONER |
PROTCETIVE ORDER MATERIAL - Exhibit 1044 - McSorely Declaration | Mar 14, 2017 | EXHIBIT | PETITIONER |
IPR2016-00712 - Opposition to Contingent Motion to Amend | Mar 14, 2017 | PAPER | PETITIONER |
IPR2016-00712 - Motion to Seal | Mar 14, 2017 | PAPER | PETITIONER |
IPR2016-00712 - Petitioners Updated List of Exhibits | Mar 14, 2017 | PAPER | PETITIONER |
Exhibit 1044 - McSorely Declaration | Mar 14, 2017 | EXHIBIT | PETITIONER |
DECISION Patent Owner's Motion for Pro Hac Vice Admission of William E. Solander | Mar 1, 2017 | PAPER | BOARD |
Patent Owner's Exhibit List 8 | Feb 23, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion for Pro Hac Vice Admission of William E. Solander | Feb 23, 2017 | PAPER | PATENT OWNER |
Exh. 2255 Declaration ISO Motion for Pro Hac Vice Admission of William E. Solander | Feb 23, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner Power of Attorney for William E. Solander | Feb 23, 2017 | PAPER | PATENT OWNER |
Patent Owner Power of Attorney Joshua I. Rothman | Feb 16, 2017 | PAPER | PATENT OWNER |
Stipulated Protective Order | Feb 15, 2017 | PAPER | PATENT OWNER |
Decision Patent Owner's Motion for Pro Hac Vice Admission of Joshua I. Rothman | Feb 10, 2017 | PAPER | BOARD |
Decision On Patent Owner's Motion to Seal | Feb 10, 2017 | PAPER | BOARD |
Notice of Deposition of Dorothee Semiond | Feb 9, 2017 | PAPER | PETITIONER |
Notice of Deposition of Patricia Matthews | Feb 9, 2017 | PAPER | PETITIONER |
Notice of Deposition of Michael E. Tate | Feb 9, 2017 | PAPER | PETITIONER |
Patent Owner's Second Update to Mandatory Notices | Feb 1, 2017 | PAPER | PATENT OWNER |
Patent Owner's Motion for Pro Hac Vice Admission of Joshua I. Rothman | Feb 1, 2017 | PAPER | PATENT OWNER |
Exh. 2254 Declaration ISO Motion for Pro Hac Vice Admission of Joshua I. Rothman | Feb 1, 2017 | EXHIBIT | PATENT OWNER |
Patent Owner's Exhibit List 7 | Feb 1, 2017 | PAPER | PATENT OWNER |
Notice of Deposition of Dr. Alton Sartor | Jan 30, 2017 | PAPER | PETITIONER |
Petitioner's Updated Mandatory Notices | Jan 30, 2017 | PAPER | PETITIONER |
Petitioner Mylan's Notice of Objections to Evidence | Jan 3, 2017 | PAPER | PETITIONER |
Exh. 2114 Avastin Press Release | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2115 Hope DailyMail Article | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2129 Sanofi-Aventis Form 20-F (2011) | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2130 Sanofi-Aventis Form 20-F (2012) | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2131 Sanofi-Aventis Form 20-F (2013) | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2133 Sanofi-Aventis Form 20-F (2015) | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2122 Small 2006 Abstract | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2123 Van Cutsem 2010 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2124 Taylor 2010 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2125 D'Amico 2014 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2126 Halabi 2013 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2127 Novacea Form 8-k (Apr. 2008) | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2128 Sanofi-Aventis 20-F (2010) | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2132 Sanofi-Aventis Form 20-F (2014) | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2142 Butler Affidavit | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2143 Billot '128 Patent | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2144 Passalacqua 1996 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2145 Ratain 2005 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2134 Sanofi-Aventis Form 20-F (2006) | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2138 About NCCN Guidelines | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2146 Prednisone Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2147 Lortholary 2000 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2148 Armstrong & Carducci 2006 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2154 Novantrone Cancer Network 1996 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2156 Provenge Approval Letter | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2157 What is Provenge | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2159 How Zytiga Works | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2160 Why Zytiga | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2166 Xofigo Approval Letter | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2151 jevtana.com/what-is-prostate-cancer | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2152 ACS Signs and Symptoms of Prostate Cancer | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2153 jevtana.com/treatment | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2155 FDA News Release 2004 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2158 Zytiga Approval Letter | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2161 Zytiga Supplemental Approval Letter | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2162 Xtandi Approval Letter | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2163 How Xtandi Works | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2164 How Xtandi May Help | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2165 Xtandi Supplemental Approval Letter | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2167 What is Xofigo Used For | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2168 FDA News Release 2013 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2170 Market Share with Docetaxel in Prior Treatment | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2150 2016 Jevtana Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2169 ACS Chemotherapy for Prostate Cancer | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2171 Monthly Jevtana Prostate Cancer Treatment Report August 2014 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2149 Confidential Tate Declaration | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2174 Zytiga Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Patent Owner Response | Dec 23, 2016 | PAPER | PATENT OWNER |
Patent Owner's Contingent Motion to Amend | Dec 23, 2016 | PAPER | PATENT OWNER |
Exh. 2181 Common Toxicity Criteria v.2 1999 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2184 Kingston 2009 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2193 McKeage 1995 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2199 Erbitux Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2200 Torisel Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2202 Camptosar Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2149 Public Tate Declaration | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2172 Red Book Data | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2173 Xtandi Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2175 Xofigo Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2177 Transcript of Deposition of Dr. Rahul Seth | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2178 Sanofi Q3 2016 Results | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2179 Data for Market Share with Docetaxel in Prior Treatment | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2180 Updated CV of Dr. Sartor | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2182 Minimum Information Required for Written Subject Information | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2183 Vrignaud 2014 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2185 Sessa 2002 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2186 Carlson 2008 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2187 Beer 2007 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2188 Holen 2004 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2189 FDA, Challenge and Opportunity White Paper 2004 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2190 Carducci 2002 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2191 Fujisaka 2006 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2192 Quinn 2013 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2194 Sessa 1998 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2195 Williams 2008 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2197 Nexavar Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2198 Gleevec Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2201 Lin 2006 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2203 Reese 1998 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2204 Alimta Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2207 Klein 2002 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2208 Gemzar Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2209 Garcia 2011 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2210 Greene 2005 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2205 Caffo 2013 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2206 Hycamtin Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2211 FDA Correspondence 2006 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2196 Provenge Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2214 Tannock 1989 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2215 Esper & Redman 1999 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2222 CNW Press Release 2012 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2226 Nagore 2000 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2212 Sartor 2016 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2213 Ruitenbeek 2008 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2216 Dagher 2004 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2217 Berthold 2008 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2218 Sanofi-Aventis Press Release July 2010 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2220 Omlin 2015 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2221 Clinicaltrials.gov CABA-DOC Patient Preference | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2223 PDR Medical Dictionary 2000 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2224 Fumoleau 2001 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2225 Abraxane Label | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2227 Reactions 2009 to Kawaguchi | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2228 Deakin & Williams 1992 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2229 Common Toxicity Criteria Manual V.2 1999 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2230 WO 2011/051894 App. No. PCT/IB2010/054866 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2231 Declaration of Art Lathers | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2232 Antonarakis 2010 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2176 Confidential Sartor Declaration | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2219 Malik Poster 2012 | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2176 Public Sartor Declaration | Dec 23, 2016 | EXHIBIT | PATENT OWNER |
Motion to Seal and Motion to Enter a Protective Order | Dec 23, 2016 | PAPER | PATENT OWNER |
Patent Owner's Exhibit List 5 | Dec 23, 2016 | PAPER | PATENT OWNER |
ORDER Conduct of the Proceeding Filing of Supplemental Information | Nov 30, 2016 | PAPER | BOARD |
Patent Owner's Notice of Deposition of Dr. Rahul Seth | Nov 25, 2016 | PAPER | PATENT OWNER |
Notice of Stipulation to Modify the Scheduling Order | Nov 21, 2016 | PAPER | PATENT OWNER |
Petitioner's Reply in Support of Motion to File Supplemental Information | Nov 11, 2016 | PAPER | PETITIONER |
Patent Owner's Opposition to Motion to Submit Supplemental Information | Nov 4, 2016 | PAPER | PATENT OWNER |
Patent Owner's Exhibit List 3 | Nov 4, 2016 | PAPER | PATENT OWNER |
Exh. 2141 Pretrial Scheduling Order, 15-cv-03392 | Nov 4, 2016 | EXHIBIT | PATENT OWNER |
Petitioner's Motion to File Supplemental Information | Oct 28, 2016 | PAPER | PETITIONER |
Exhibit 1039 - Amended Claim Construction Memorandum Opinion and Order | Oct 28, 2016 | EXHIBIT | PETITIONER |
EXPUNGED | Oct 28, 2016 | EXHIBIT | PETITIONER |
Patent Owner's Updated Mandatory Notices | Oct 14, 2016 | PAPER | PATENT OWNER |
Patent Owner's Objections to Evidence Submitted by Mylan with the Petition | Oct 6, 2016 | PAPER | PATENT OWNER |
Petitioner Mylan Laboratories Limited's Notice of Objection to Evidence | Oct 6, 2016 | PAPER | PETITIONER |
Trial Instituted Document | Sep 22, 2016 | PAPER | BOARD |
Scheduling Order | Sep 22, 2016 | PAPER | BOARD |
2016.6.24 Preliminary Response by Patent Owner Pursuant to 37 CFR 42.107 | Jun 24, 2016 | PAPER | PATENT OWNER |
2016.6.24 Patent Owner's Exhibit List 1 | Jun 24, 2016 | PAPER | PATENT OWNER |
Exh. 2001 Sartor Declaration | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2002 Sartor CV | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2003 Larotaxel MBC EFC6089 Summary | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2004 Antonarakis | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2005 Armstrong | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2006 Beer | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2007 Berry | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2008 BMS Yervoy Press Release | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2009 Cabral | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2010 Carducci | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2011 D'Amico | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2012 Yervoy Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2013 Didier, 2005/0065138 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2014 Di Lorenzo | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2015 Dieras Larotaxel MBC | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2016 Dumontet | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2017 Halabi | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2018 Higano | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2019 Avastin Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2020 Kaur | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2021 Kola | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2022 Larotaxel vs. Capecitabine clinicaltrials.gov | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2023 Larotaxel vs. Gemcitabine clinicaltrials.gov | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2024 Larotaxel vs. 5-FU clinicaltrials.gov | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2025 Mackinnon | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2026 Michaelson | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2027 Mulcahy | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2028 Novacea Form 8-K | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2029 OncoGenex Press Release | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2030 Ramiah | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2031 Roche Press Release | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2032 Satraplatin clinicaltrials.gov | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2033 Slovin | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2034 Small GVAX | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2035 Small Ipilimumab | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2036 Sternberg | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2037 Susan | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2038 Takeda Press Release | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2039 Gupta 2012/0301425 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2040 Van Cutsem | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2041 Van Hook | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2042 Wiechec | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2043 Williams | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2044 Wirth | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2045 Zatloukal | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2046 Zielinski | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2047 Cancer Facts and Figures 2009 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2048 Baselga 2005 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2049 Baselga 1999 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2050 Bissery | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2051 Chen | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2052 Cisternino | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2053 Cobleigh | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2054 De Bono 2007 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2055 De Bono 2010 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2056 EMA Clinical Trials Guidance | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2057 Federal Register Residual Solvents | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2058 FDA Press Release Taxotere Prostate Cancer | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2059 FDA Press Release Approval of Jevtana | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2060 Fukuoka | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2061 Gianni | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2062 Hande | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2063 Herceptin Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2064 Last Hope Article | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2065 Iressa Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2066 Ixempra Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2067 Jevtana Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2068 Sanofi-Aventis Press Release Phase III Publication | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2069 Liu Excerpts | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2070 Lokich | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2071 Malhotra | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2072 Markman Hearing Transcript Excerpts | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2073 Mokbel | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2074 Morant | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2075 Motzer | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2076 NCCN Guidelines 2009 Breast | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2077 NCCN Guidelines 2009 Prostate | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2078 National Horizon Scanning Centre | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2079 Niho | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2080 Pazdur | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2081 Perez-Soler | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2082 Perjeta Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2083 Pienta | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2084 Ramanathan | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2085 Reck | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2086 Defendants Joint Claim Construction Brief Excerpt | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2087 SEC 20-F Compilation Jevtana Sales | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2088 Spigel | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2089 Straub | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2090 Sutent Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2091 Takeda 2007 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2092 Tarceva Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2093 Taxol Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2094 Ten Tije | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2095 Vogel | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2096 Vrignaud | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2098 Xeloda Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2099 Ziada | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2100 Clinicaltrials.gov Listing for TROPIC 2006 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2101 Dieras Larotaxel plus Trastuzumab | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2102 Sanofi-Aventis Form 20-F 2006 | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2103 Butler | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2104 Canil | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2105 Mononen | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2106 Saad | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2107 Sonpavde | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2108 Taylor | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2109 Mubiru | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2110 Latif | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2111 Novantrone Label | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2112 Small Gefitinib | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Exh. 2113 Joffe | Jun 24, 2016 | EXHIBIT | PATENT OWNER |
Patent Owner's Mandatory Notices | Apr 5, 2016 | PAPER | PATENT OWNER |
Power of Attorney | Apr 4, 2016 | PAPER | INDICATES ARTIFACT WAS SUBMITTED ON BEHALF OF POTENTIAL_PATENT OWNER. |
Notice of Filing Date Accorded to Petition | Mar 24, 2016 | PAPER | BOARD |
Power of Attorney | Mar 15, 2016 | PAPER | PETITIONER |
Related Matters | Mar 15, 2016 | PAPER | PETITIONER |
Petition for IPR re US 8,927,592 | Mar 15, 2016 | PAPER | PETITIONER |
Exhibit 1001 - US 8,927,592 to Gupta | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1002 - Declaration of Dr. Rahul Seth | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1003 - CV of Rahul Seth | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 1 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 2 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 3 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 4 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 5 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 6 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 7 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 8 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 9 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 10 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 11 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 12 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1004 - File History of US 8,927,592 - Part 13 of 13 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1005 - U.S. Provisional Patent Application No. 61256160 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1006 - U.S. Provisional Patent Application No. 61293903 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1007 - U.S. Provisional Patent Application No. 61355834 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1008 - Sanofi-Aventis XRP6258 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1009 - Winquist et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1010 - Pivot et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1011 - US 7,241,907 to Didier et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1012 - Mita et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1013 - Tannock et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1014 - Complaint in 15-cv-03392 | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1015 - Booth et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1016 - Steadmans | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1017 - Abrams et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1018 - Kelland and Abel | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1019 - Verweij et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1020 - Galletti et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1021 - Attard et al | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1022 - Beardsley and Chi | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1023 - El-Maraghi | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1024 - Taxotere Label | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1025 - Liu | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1026 - Affidavit of Christopher Butler | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1027 - Rosenberg | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1028 - Gayther | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1029 - Ratain | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1030 - Moul | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1031 - Joint Statement | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1032 - Hopkins | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1033 - Hospers | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1034 - Zhu | Mar 15, 2016 | EXHIBIT | PETITIONER |
Exhibit 1035 - Markman Transcript | Mar 15, 2016 | EXHIBIT | PETITIONER |